SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-135561
Filing Date
2020-05-07
Accepted
2020-05-07 07:02:01
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d888492d10q.htm 10-Q 451670
2 EX-31.1 d888492dex311.htm EX-31.1 11362
3 EX-31.2 d888492dex312.htm EX-31.2 11347
4 EX-32.1 d888492dex321.htm EX-32.1 5538
11 GRAPHIC g888492g0421103741516.jpg GRAPHIC 34551
  Complete submission text file 0001193125-20-135561.txt   3561786

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT meip-20200331.xml EX-101.INS 676941
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20200331.xsd EX-101.SCH 35627
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20200331_cal.xml EX-101.CAL 26985
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20200331_def.xml EX-101.DEF 266100
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20200331_lab.xml EX-101.LAB 332544
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20200331_pre.xml EX-101.PRE 295010
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 20854509
SIC: 2834 Pharmaceutical Preparations